Colgate-Palmolive (CL) is back in focus after two fresh headlines: a 63rd consecutive annual dividend increase and the launch of its Colgate Optic White Pro Series Toothpaste, both relevant for income focused and growth oriented investors.
See our latest analysis for Colgate-Palmolive.
At a share price of US$85.12, Colgate-Palmolive has seen a 10.94% 1 month share price decline and a 4.19% 7 day pullback, even though the 90 day share price return of 8.63% and 3 year total shareholder return of 24.47% point to momentum built over a longer horizon.
If recent dividend news has you rethinking where to find dependable growth, it could be a good time to broaden your search and check out 20 top founder-led companies
So after a short term pullback, despite a 3 year total shareholder return of 24.47% and recent product and dividend announcements, is Colgate-Palmolive trading at a discount, or is the market already pricing in future growth?
Most Popular Narrative: 12.4% Undervalued
Colgate-Palmolive's most followed valuation narrative places fair value at about $97.21 versus the last close of $85.12, framing the recent pullback as a discount to that estimate.
Expansion and premiumization of core oral care lines like Colgate Total, coupled with the roll-out of complementary products across 75 markets, are set to capture increased value from emerging middle-class consumers and rising health/hygiene awareness globally, which in turn supports top-line organic sales acceleration and improved pricing power.
Curious what has to happen for that higher value to make sense? Revenue pacing, margin lift and the future earnings multiple all play a central role.
Result: Fair Value of $97.21 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, that upside story could be challenged if cautious consumers keep volumes under pressure in key markets or if higher raw material and packaging costs squeeze margins.
Find out about the key risks to this Colgate-Palmolive narrative.
Another View: Ratios Point To A Richer Price
While the SWS DCF model suggests Colgate-Palmolive is trading at a 32.1% discount to an estimated fair value of $125.40, the P/E ratio of 32x tells a different story, sitting above the fair ratio of 27.8x and well ahead of both the global industry at 16.4x and peers at 22.1x. This raises the question of whether the market could eventually pull that multiple closer to the fair ratio instead.
For investors comparing these signals, it helps to see how the current earnings multiple stacks up visually and how sensitive it might be if sentiment shifts toward that fair ratio. You can gauge this through See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Given the mix of optimism and caution in these narratives, it makes sense to move quickly and check the facts for yourself so your view is grounded in the full picture, including 3 key rewards and 3 important warning signs.
Looking for more investment ideas?
If you stop at just one stock, you risk missing other opportunities that could better match your goals, cash flow needs and comfort with risk.
- Target potential mispricings by scanning for companies that combine quality fundamentals with attractive entry points through 52 high quality undervalued stocks
- Strengthen the income side of your portfolio by focusing on reliable cash payouts using the 13 dividend fortresses
- Spot future contenders early by filtering for smaller, underfollowed businesses with solid numbers via the screener containing 26 high quality undiscovered gems
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com